Vivanza Biosciences

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue6.144.893.923.392.27
Expenses6.084.563.743.202.53
EBITDA0.170.440.300.28-0.16
EBIT0.160.440.300.28-0.18
Profit Before Tax0.070.330.190.18-0.27
Net Profit-0.050.330.190.18-0.38
Financial Ratios
Operating Profit Margin2.82%9.02%7.75%8.31%-6.96%
Net Profit Margin-0.83%6.76%4.91%5.34%-16.52%
Earning Per Share (Diluted)-0.140.080.050.05-0.09
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ